Recent Quarter Total Invested
$1.85 M
Recent Quarter Institutional Ownership Percentage
22.34%
Total Invested of Last Quarter
$1.48 M
Ownership Percentage of Last Quarter
21.37%
NLS Pharmaceutics AG Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BVF INC/IL | 08/14/2024 | 5.75 M | $1.25 M | 0.00% | 15.05% |
| ARMISTICE CAPITAL, LLC | 08/14/2024 | 2.31 M | $501,256 | 6.40% | 6.05% |
| UBS GROUP AG | 08/14/2024 | 235,723 | $51,152 | 100.00% | 0.62% |
| CITADEL ADVISORS LLC | 08/14/2024 | 136,270 | $29,557 | 610.37% | 0.36% |
| JANE STREET GROUP, LLC | 08/15/2024 | 43,672 | $9,473 | 100.00% | 0.11% |
| RENAISSANCE TECHNOLOGIES LLC | 08/09/2024 | 21,777 | $4,723 | -87.87% | 0.06% |
| HRT FINANCIAL LP | 08/12/2024 | 16,832 | $3,000 | 100.00% | 0.04% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 14,362 | $3,115 | 0.00% | 0.04% |
| BANK OF AMERICA CORP /DE/ | 08/14/2024 | 90 | $19 | 0.00% | 0.00% |
| XTX TOPCO LTD | 08/12/2024 | 0 | $0 | -100.00% | 0.00% |
NLS Pharmaceutics AGinstitutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of NLSP shares?
During the previous two years, 10 institutional investors and hedge funds held shares of NLS Pharmaceutics AG. The most heavily invested institutionals were:
BVF INC/IL: 5.75 M
ARMISTICE CAPITAL, LLC: 2.31 M
UBS Group AG: 235,723
CITADEL ADVISORS LLC: 136,270
JANE STREET GROUP, LLC: 43,672
RENAISSANCE TECHNOLOGIES LLC: 21,777
-
What percentage of NLS Pharmaceutics AG stock is owned by institutional investors?
22.34% of NLS Pharmaceutics AG stock is owned by institutional investors.
-
How much institutional buying is happening at NLSP ?
Institutional investors have bought a total of 8.53 M shares in the last 24 months. This purchase volume represents approximately $33.00 M in transactions.